In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
September 2020 -. Baxter International Inc. made an announcement regarding the U.S. FDA approval of Clinimix and Clinimix E which consists of higher protein content mainly for patients who require parenteral nutrition.
Parenteral nutrition refers to the intravenous feeding of nutrient solutions to patients. It is a process by which liquid nutrients are injected into the body through the veins. It is generally used in a medical condition where a patient is not able to get enough nutrients through the food due to the obstruction of the gastrointestinal tract. This leads to the insufficient nourishment of the body.
Parenteral nutrition is usually designed for people suffering from Crohn’s disease, short bowel syndrome, and cancer. It helps to prevent malnutrition in patients who are unable to obtain adequate nutrients by oral or enteral routes.
The global parenteral nutrition market is anticipated to record a high CAGR during the forecast period, i.e., 2020-2028. This is attributed to the presence of a large number of undernourished children, rising occurrence of cancer, and increasing premature births around the globe.
The market is segmented by nutrient type, consumer, and by end-user, out of which, the nutrient segment is further categorized into carbohydrates, lipid emulsion, single dose amino acid solution, trace elements, and vitamins & minerals. The segment for single dose amino acid solutions is projected to hold a significant market share during the forecast period owing to its extensive use in numerous parenteral therapies for the treatment of chronic diseases. The lipid emulsion segment is also expected to witness significant growth in the parenteral nutrition market on the back of growing cases of pediatric patients worldwide. Lipid emulsions are a rich source of essential fatty acids and are used to uphold the nitrogen level in parenteral nutrition solutions and are therefore responsible for the growth of the global parenteral nutrition market over the forecast period.
Based on the consumer, the segment for children and new-borns is assessed to hold the largest market share during the forecast period on account of the rising birth rates and premature births along with the scarcity of essential nutrients in premature infants and newborns.
Based on the end-user, the market is segmented into hospitals, clinics, and others. The segment for the hospital is estimated to hold the largest share in the global parenteral nutrition market over the forecast period which is attributed to the growing cases of inflammatory bowel syndrome and cancer-induced anemia patients globally coupled with the increasing demand for advanced healthcare facilities. The clinical segment is also anticipated to register a fast growth in terms of revenue over the forecast period as a result of the increasing number of specialized and disease-specific clinics which is estimated to contribute to the internal competition for better service and thereby raise the global demand for parenteral nutrition market.
Poverty is a big factor leading to malnutrition in older people. Many old people suffer from various disabilities, functional impairments, or chronic diseases. The rise in the medication, healthcare, and utility costs leads them to cut back on their food budget and as a result, they are unable to shop for groceries or cook for themselves and so they compromise on their diet which leads them to malnutrition.CLICK TO DOWNLOAD SAMPLE REPORT
Additionally, growing incidences of chronic diseases such as cancer, Chron’s disease, and others, influence the usage of parenteral nutrition around the globe. According to WHO, the number of cancer-related deaths around the world is projected to increase by 45%[AS1] between 2008 to 2030. Thus, the increasing number of government initiatives and healthcare organizations to spread awareness on the importance of a balanced diet coupled with the rising cases of cancer-related problems and inflammatory bowel syndromes are some of the key factors expected to drive the growth of the global parenteral nutrition market during the forecast period.
Malnutrition is one of the key drivers in the parenteral nutrition market. According to the UNICEF, the unbalanced nutritional intake in babies during their initial few days after the birth may lead to diminished cognitive capacity and stunted development. Thus, the rise in the occurrences of malnutrition among children especially in developing and some developed nations across the globe, coupled with the need to properly balance the diets with vitamins, minerals, amino acids, lipids, and others nutrients are some of the major factors expected to further drive the growth of the global parenteral nutrition market.
Furthermore, an increasing number of C-section deliveries, premature births, and severely undernourished mothers giving birth to weak children are other prominent factors that are projected to accelerate the growth of the parenteral nutrition market over the forecast period.
Various side effects are associated with the inappropriate usage of parenteral nutrition such as re-feeding syndrome, catheter infections, particulate contamination, and liver dysfunction to the patients undergoing the therapy. These factors are estimated to hamper the market growth. The long-term usage of parenteral nutrition therapy significantly increases the risk of liver diseases, infections, and metabolic complications in patients. These factors coupled with the increasing demand for enteral nutrition is predicted to decrease the growth of the global parenteral nutrition market during the forecast period.